Pacific Biosciences Of California | PACB - Pre Tax Profit


Pacific Biosciences Of California reported $-60.72M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Agilent USD 442M 1000K Sep/2025
Bruker USD -72.6M 73.1M Sep/2025
Danaher USD 1.08B 421M Sep/2025
General Electric Aerospace USD 2.85B 337M Dec/2025
Illumina USD 220M 86M Sep/2025
Myriad Genetics USD 6.2M 2.1M Dec/2024
Pacific Biosciences Of California USD -60.72M 112.59M Sep/2024
Quidel USD -756.9M 527.3M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Standard Biotools USD -32.9M 14.62M Sep/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Waters USD 170.12M 7.57M Sep/2025